Expert commentary highlights evidence gaps and infrastructure needs in global immunization, indicating critical priorities for evolving vaccine development.
World Vaccine Congress Washington 2026, held at the Walter E. Washington Convention Center from March 30 to April 2, brought together senior leaders from governments, global health organizations, academia, and industry to examine how the vaccine landscape must evolve in response to shifting scientific, political, and economic realities. Vaccine Insights spoke with four leading voices: Simon van Haren, Marion Gruber, Michael Osterholm, and Rajinder Suri, on the evidence gaps, population blind spots, and infrastructure challenges shaping the future of vaccines. Read the full infographic below
No takes yet. Share an insight, caveat, or question.
Cannon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: